HairDX Selling Genetic Baldness Test To doctors just.

Corey Fuentes

30 June 2008

As an element of its attempts to develop new pharmagenomic prescription based therapies for hair loss in men and girls, HairDX will concentrate on its worldwide network of consultants for its current and future products. "Given the doubtful regulatory environment that rules direct to shopper genetic testing, we made a decision to target our core business, the analysis and development of new prescription based therapies for hair loss tailored to an individual's genetic makeup" claims HairDX head honcho Andy Goren. The company had formerly made the straightforward test available immediately to the customer online, providing data about an individual's genetic risk for hair loss ( Androgenetic Alopecia ). HairDX uses a CLIA certified laboratory ( Clinical Laboratory Improvement Amendments ) to perform the genetic research, offering consultants a robust screening test for Androgenetic Alopecia before any plain indications of hair loss.